| Model ID | 13-053-02 |
| Model Name | NYC Risk Score - Valve/CABG |
| Pubmed ID | 23357609 |
| First Author | Hannan |
| Journal | Annals of Thoracic Surgery |
| Year | 2013 |
| Title | Risk score for predicting in-hospital/30-day mortality for patients undergoing valve and valve/coronary artery bypass graft surgery |
| Primary Index Condition | Cardiac Surgery |
| Secondary Index Condition | N/A |
| Outcome | Mortality |
| Model Sample Size | 8373 |
| Cohort Sample Size | 8373 |
| Number of Events | 552 |
| Follow-Up Duration | Short (<3 months) |
| AUROC | 0.757 |
| Calibration Reported | 1 |
| Covariates | Intercept; Type of valve/CABG surgery: aortic valve replacement/CABG; Type of valve/CABG surgery: mitral valve replacement/CABG; Type of valve/CABG surgery: mitral valve repair/CABG; Type of valve/CABG surgery: mitral valve repair or replacement/CABG; Age between 75 and 84 years; Age 85 or more; Sex and BSA: male and BSA >=2.5; Sex and BSA: female and BSA <1.5; Sex and BSA: female and BSA >=1.5 to <1.75; Sex and BSA: female and BSA >=2.25; Sex and BSA: all others; Hemodynamically unstable; Ejection fraction <30%; Previous MI within 1 day; Previous MI 1 to 14 days; Endocarditis; Peripheral vascular disease; Renal failure: creatinine 2.1-2.5 mg/dL; Renal failure: creatinine >2.5 mg/dL; Renal failure: requiring dialysis; Left main disease; Previous open heart operations; Previous PCI before this admission |
| Mesh Terms | To be updated |
| Number of Validations | 3 |
